A new dual CAR-T therapy is developed against non-Hodgkin lymphoma
Researchers at IDIBAPS- Hospital Clínic have developed and validated a new CAR-T therapy called ARI0003 at a preclinical level. The new therapy com...
Researchers at IDIBAPS- Hospital Clínic have developed and validated a new CAR-T therapy called ARI0003 at a preclinical level. The new therapy com...
A team from Clínic-IDIBAPS led a collaborative study that characterized in detail the genetic profile of testicular B-cell lymphoma, a very rare ly...
An international study published in the journal Nature has identified 36 genes involved in the onset and development of bipolar disorder and the fa...
The National Cancer Institute of the National Institutes of Health (NIH) will fund a project that aims to decipher the molecular mechanisms by whic...
Researchers from Hospital Clínic-IDIBAPS have led a study that has found a correlation between anti-tumour immunological activity and longevity in...
The AES25 call includes a section for recruiting bioinformatics technicians to support research at health research institutes. IDIBAPS is seeking c...
The ALIVE clinical trial shows that a tablet combining albendazole and ivermectin is safe and more effective than albendazole alone in treating soi...
The journal The Lancet has published the results of a phase III clinical trial led by Josep Maria Llovet, from IDIBAPS-Hospital Clínic Barcelona. I...
A team from Clínic-IDIBAPS has introduced a modification to a CAR-T immunotherapy for multiple myeloma that makes it more durable, according to res...